Share your 23andMe data with a digital genetics study
Part of Heart & circulation clinical trials.
This study tests a digital platform that uses people’s existing genetic information to support genetic research. If you are an adult and willing to share your 23andMe results from an Apple phone, you can likely participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a 23andMe account and are willing to share your genetic data
- You use an Apple mobile device (like an iPhone or iPad with cellular)
- You must be 18 years old or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app to help Black and non-White Hispanic adults with heart or blood sugar conditions. It aims to make research easier to join from home and understand why some groups don't participate.
This study uses a wearable wrist device to monitor your health data and look for early signs of heart problems. It's for people with or without heart disease, and involves wearing a watch-like device and using a smartphone app.
This study collects and stores DNA samples and related health information from people of all ages. It helps researchers understand childhood diseases better and may support future discoveries and treatments.
This study uses your blood to create special lab cells (induced pluripotent stem cells) to better understand heart-related differences between people with coronary artery disease and generally healthy older adults. It may help researchers learn what biological traits are linked to heart risk and how those traits work.
This trial asks you to share your lifestyle and health data through a smartphone app or website. It aims to make heart disease prevention more inclusive. If you want, you can also join a 12-week program for personalized health tips.
This study tests new, personalized ways to prevent heart disease in people with metabolic syndrome. It aims to see if custom approaches can lower your risk of heart attacks and strokes.
Hear when a new Heart Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.